NCT04709458 2022-05-03Safety and Early Efficacy Study of TBX-2400 in Patients With AML or MyelofibrosisTaiga Biotechnologies, Inc.Phase 1 Unknown10 enrolled
NCT00769613 2013-12-18Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsNational Cancer Institute (NCI)Phase 1 Unknown20 enrolled